Atractylenolide III reduces NLRP3 inflammasome activation...

  • Main
  • 2020 / 03
  • Atractylenolide III reduces NLRP3 inflammasome activation...
Clinical and Experimental Pharmacology and Physiology 2020 / 03

Atractylenolide III reduces NLRP3 inflammasome activation and Th1/Th2 imbalances in both in vitro and in vivo models of asthma

Zhu, Cuimin, Zhang, Leguo, Liu, Zhiming, Li, Chen, Bai, Yajie, Wang, Linlin
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Clinical and Experimental Pharmacology and Physiology
DOI:
10.1111/1440-1681.13306
Date:
March, 2020
File:
PDF, 12.50 MB
2020
Conversion to is in progress
Conversion to is failed